Sangamo Therapeutics(SGMO)

泼天财富我自来07-26 10:27

$Sangamo Therapeutics(SGMO)$ 补充更新一下
2024/7/24 该公司公布和辉瑞合作开发血友病基因药物三期达标，股价暴涨，后续可期！查看全文

产业链观察07-24 21:24

#药闻简讯# 2024 年 7 月 24 日，$辉瑞(PFE)$ 今天宣布了评估giroctocogene fitelparvovec的3期研究（NCT04370054）的积极顶线结果，该研究是一种用于治疗中度至重度血友病A成人的研究性基因疗法。$Sangamo Therapeutics(SGMO)$查看全文

当期报告

Sangamo Therapeutics(SGMO)2023-11-04 04:05

$Sangamo Therapeutics(SGMO)$ 8-K Current report, item 8.01 Accession Number: 0001628280-23-036697  Act: 34  Size: 1 MB 网页链接查看全文

员工持股计划

Sangamo Therapeutics(SGMO)2023-08-09 04:55

$Sangamo Therapeutics(SGMO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-23-206301  Act: 33  Size: 73 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)2023-08-30 04:25

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-047586  Size: 6 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)2023-08-30 04:25

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-047590  Size: 6 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)01-25 05:45

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001756  Size: 6 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)01-25 05:45

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001754  Size: 6 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)01-25 05:45

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001755  Size: 6 KB 网页链接查看全文

其他

Sangamo Therapeutics(SGMO)04-20 04:25

$Sangamo Therapeutics(SGMO)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-102893  Act: 34  Size: 17 MB 网页链接查看全文

Stockslover2018-09-05 21:55

$Sangamo Therapeutics, Inc.(SGMO)$ 为什么这只股跌的那么厉害？虽然不玩美股查看全文

淘沙见金2018-09-05 09:27

$Sangamo Therapeutics, Inc.(SGMO)$ 重磅数据明天公布，这里分享一下Jefferies Note:
SGMO's update tomorrow at SSIEM looks set to be an important one -- more about demonstrating proof-of-concept (can SGMO edit hepatocytes?) than producing clinically relevant MPS II data (...查看全文

现在投机而立家2018-08-19 07:05

$Sangamo Therapeutics, Inc.(SGMO)$ 9月头出结果 大家怎么看~查看全文

群氓鄙陋2018-08-16 22:58

$Sangamo Therapeutics, Inc.(SGMO)$ 如果大盘不行，类似这样的医药股会怎么样？查看全文

专业不动2018-08-10 00:48

$Sangamo Therapeutics, Inc.(SGMO)$看了半天，没敢动手，胆子越来越小了。查看全文

usbiostock2018-08-01 23:26

移除PGNX，更新$Sangamo Therapeutics, Inc.(SGMO)$ ，新增$Audentes Therapeutics, Inc.(BOLD)$ ，$uniQure N.V. - Ordinary Shares(QURE)$查看全文

usbiostock2018-08-01 09:35

回复@PharmSeeker: $Sangamo Therapeutics, Inc.(SGMO)$ 从老鼠的数据看，我感觉还可以，IDS活性在多器官中均显著上升，GAG除了脑下降不太显明显，其它器官也都有显著下降，巴恩斯迷宫也显示认知功能提升。但老鼠数据也只能作为参考，没有NHP的数据，比较难下结论。这次的数据我主要关注安全性和ID...查看全文

usbiostock2018-08-01 05:08

$Sangamo Therapeutics, Inc.(SGMO)$ 公司将在2018年9月5日举办的SSIEM会议上更新-913 治疗MPS II 临床 1/2期试验（CHAMPIONS研究）初始安全性和有效性数据。查看全文

anne_nie2018-07-24 01:01

$Sangamo Therapeutics, Inc.(SGMO)$ 有什么不好消息吗？查看全文

淘沙见金2018-07-16 23:31

感觉 $Sangamo Therapeutics, Inc.(SGMO)$ 数据可能不太好， $Spark Therapeutics, Inc. (ONCE)$ 数据也不看好。 $凯赛生物(CBIO)$ 这个涨的真是不错查看全文

上行空间均超50%，RBC力荐这三只潜力股

智通财经APP获悉，近期，RBC针对Verrica Pharmaceuticals(VRCA.US)、Sangamo Therapeutics(SGMO.US)、GooseHead Insurance(GSHD.US)三家公司发表研报，并强调了这三只股票未来强劲的长期增长前景，预计在未来一年的上行空间将至少达到50... 网页链接

当期报告

$Sangamo Therapeutics(SGMO)$ 8-K Current report, item 8.01 Accession Number: 0001628280-24-032815  Act: 34  Size: 287 KB 网页链接

超过5%股东持股披露「修订」

$Sangamo Therapeutics(SGMO)$ SC 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001086364-24-008122  Act: 34  Size: 12 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016686  Size: 6 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015752  Size: 8 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015753  Size: 7 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015754  Size: 7 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015755  Size: 8 KB 网页链接

当期报告

$Sangamo Therapeutics(SGMO)$ 8-K Current report, items 5.02, 5.03, 5.07, and 9.01 Accession Number: 0001628280-24-026903  Act: 34  Size: 13 MB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014796  Size: 9 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014798  Size: 9 KB 网页链接